May 14, 2020
Oncopeptides announces new clinical and preclinical melflufen data at the upcoming European Hematology Association meeting
Media
May 14, 2020
Targovax announces that the ONCOS-102 and durvalumab abstract is selected for a Poster Discussion Session at ASCO
May 13, 2020
Oncopeptides announces that two abstracts on multiple myeloma have been accepted by the 2020 ASCO Annual Meeting
May 12, 2020
Spruce Biosciences Announces Launch of CAHstudy.com to Initiate Screening of Patients for CAH Clinical Program
May 11, 2020
Strongbridge Biopharma plc Announces Completion of Enrollment of Phase 3 LOGICS Study for RECORLEV® (levoketoconazole) for Endogenous Cushing’s Syndrome
May 11, 2020
Orexo acquires exclusive US rights to commercialize deprexis®, a world-leading digital therapy to help patients manage the symptoms of depression
May 08, 2020
BONESUPPORT HOLDING AB (PUBL) – Publishes Q1 2020 Interim report
May 07, 2020
Targovax ASA: First quarter 2020 results
May 06, 2020
Strongbridge Biopharma plc Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 06, 2020
Spruce Biosciences Strengthens Leadership Team with Appointments of Samir Gharib as CFO and Dasharatha Reddy as VP of Pharmaceutical Development and Manufacturing
